{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-01-01T12:25:11.049511+00:00",
  "news": [
    {
      "title": "VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxOellNM0FjaEhMM2R6NGtYQ3NXeDc4MkVIclVYWVd3THIzU2IwUnpkN29IRVFLYmFScnRpakREQkJNbXhxclNpdWxoYVBaY0t1SS1ISnIwOGhhdnM2eUVMMzdBSnV5ZzVSY0tTVVZrbnZ0Q3JidlZ3a055SjZjSjdBWl9YbVNMVFN6ZVN2RXU5MmRsWUlrVmJqd2Z0ejlWSnVTMWV0MkxHWGMwTHdRdjQtVVZLTDhfMTFYQnE0am9XUjNmUVdfOXlxMi12SGEtRWF1aE4wS09kdzEtR0VZamgxNlBHOGxZd3VTN1pPRXlhNTU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8AFBVV95cUxOellNM0FjaEhMM2R6NGtYQ3NXeDc4MkVIclVYWVd3THIzU2IwUnpkN29IRVFLYmFScnRpakREQkJNbXhxclNpdWxoYVBaY0t1SS1ISnIwOGhhdnM2eUVMMzdBSnV5ZzVSY0tTVVZrbnZ0Q3JidlZ3a055SjZjSjdBWl9YbVNMVFN6ZVN2RXU5MmRsWUlrVmJqd2Z0ejlWSnVTMWV0MkxHWGMwTHdRdjQtVVZLTDhfMTFYQnE0am9XUjNmUVdfOXlxMi12SGEtRWF1aE4wS09kdzEtR0VZamgxNlBHOGxZd3VTN1pPRXlhNTU?oc=5\" target=\"_blank\">VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-01T11:34:35+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Vertex Pharmaceuticals: Prepared To Defend Their Dominance And Expand Their Expertise - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNjFaUkd0ODNBWW9SelU0Y0NtQ3JDT1NhZlRVSmsybURHRXBNLW5jbEt4NVNBbHVDbzNQQ0dNdUE4ZHBTMG4tV3o3UVNzaDZoNzhlQ1pvc1BpX01icUgwX1ZsSkd0bUFrUUpRRUh3SDRJakFOcG9KZHppc0U2X0FZLXYxdTFxRTFpX21TWHdzd1pyNk9RRk1yUUFKaUlXZ3U0MEtIdWFCbkdXd1E0OFgweHladHEzeFBQTUlV?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNjFaUkd0ODNBWW9SelU0Y0NtQ3JDT1NhZlRVSmsybURHRXBNLW5jbEt4NVNBbHVDbzNQQ0dNdUE4ZHBTMG4tV3o3UVNzaDZoNzhlQ1pvc1BpX01icUgwX1ZsSkd0bUFrUUpRRUh3SDRJakFOcG9KZHppc0U2X0FZLXYxdTFxRTFpX21TWHdzd1pyNk9RRk1yUUFKaUlXZ3U0MEtIdWFCbkdXd1E0OFgweHladHEzeFBQTUlV?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Prepared To Defend Their Dominance And Expand Their Expertise</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-12-31T04:59:42+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex Pharmaceuticals price target raised to $525 from $456 at Leerink - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNcUUwSHZtUFNlcWlHQmp6QjlUcDlqQVpnZmwwRVJqQmZnb2VrVk0yUW9BSW03SG9MTEdtWnk3Rk1UUTVaRDVDSThqRjNRZDM3UDBqTEJmbURyMnpBdE83MzVMZG13ckJpSG1PYWY5UUM4cW10bXMyM1BJRndsRWNfTUdqaUFQbUZSSlJvcDE2U3ltdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxNcUUwSHZtUFNlcWlHQmp6QjlUcDlqQVpnZmwwRVJqQmZnb2VrVk0yUW9BSW03SG9MTEdtWnk3Rk1UUTVaRDVDSThqRjNRZDM3UDBqTEJmbURyMnpBdE83MzVMZG13ckJpSG1PYWY5UUM4cW10bXMyM1BJRndsRWNfTUdqaUFQbUZSSlJvcDE2U3ltdw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals price target raised to $525 from $456 at Leerink</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-30T13:10:34+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Our Science | Video Series - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE40aEVYaDN2bnhWQklQMlRJT3BHT3lBUUsyWlZWR0c4bDFVYVlPdkVIZ1YwamdIeXR6Vzd2eXBROVJLUnJxU3ZKWVlfTnVHUDFFeGVBZi1yNGNzVjRB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiXEFVX3lxTE40aEVYaDN2bnhWQklQMlRJT3BHT3lBUUsyWlZWR0c4bDFVYVlPdkVIZ1YwamdIeXR6Vzd2eXBROVJLUnJxU3ZKWVlfTnVHUDFFeGVBZi1yNGNzVjRB?oc=5\" target=\"_blank\">Our Science | Video Series</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-12-19T13:07:09+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "The Best Stocks to Invest $1,000 in to Start the New Year Off Right - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPUktOdDhfLXdFUVpGREVnT2NvaWEzcDZpZU9aMmdFZXdCVmVpNlpoMVp2enNGMVdsOHVmLWdBQ21DaXBXR2lwUnhnQXB3MUxwa2w1cmZYbU0wZ1RBdG1XMDBQeFR1VFJ3V3B2NDB0Z3JFdlVadkRVZW40RGxpeWYxRnB2bDdGU1dISTlvS1VTY3V0ZkdXTjZ4YVVvTTUxcEM2aUJNVnRIeUxDcnl5VHdERTdFWEpMQTdyNmh2d3BRNHFROHQ0NHRZNUE4dVAyVGptUE1UUm5EWlNESFVfRFB2TThKckppWE1u?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPUktOdDhfLXdFUVpGREVnT2NvaWEzcDZpZU9aMmdFZXdCVmVpNlpoMVp2enNGMVdsOHVmLWdBQ21DaXBXR2lwUnhnQXB3MUxwa2w1cmZYbU0wZ1RBdG1XMDBQeFR1VFJ3V3B2NDB0Z3JFdlVadkRVZW40RGxpeWYxRnB2bDdGU1dISTlvS1VTY3V0ZkdXTjZ4YVVvTTUxcEM2aUJNVnRIeUxDcnl5VHdERTdFWEpMQTdyNmh2d3BRNHFROHQ0NHRZNUE4dVAyVGptUE1UUm5EWlNESFVfRFB2TThKckppWE1u?oc=5\" target=\"_blank\">The Best Stocks to Invest $1,000 in to Start the New Year Off Right</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2026-01-01T11:06:30+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Momentum Stock - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNajRXdWoxb1k1cUFzbm5fY1dwdEFCb0xZRUY3WTU2ckk0RV9SQUV0SThNYVluVGNGNGRQZ0RPVVowRG56d2lEWkpubmlSdWp2d1d0dS0xMGdvSS13RjMwMTRVS2c4WEtzSVNVNkx5Y1pZWmpXTDhOUWRMRVNpcHJhSjBTX092Nnc3dmJCZXlJQ2hGOHZ3THc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxNajRXdWoxb1k1cUFzbm5fY1dwdEFCb0xZRUY3WTU2ckk0RV9SQUV0SThNYVluVGNGNGRQZ0RPVVowRG56d2lEWkpubmlSdWp2d1d0dS0xMGdvSS13RjMwMTRVS2c4WEtzSVNVNkx5Y1pZWmpXTDhOUWRMRVNpcHJhSjBTX092Nnc3dmJCZXlJQ2hGOHZ3THc?oc=5\" target=\"_blank\">Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Momentum Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2025-12-30T14:50:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Where Will Vertex Pharmaceuticals Be in 5 Years - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxORjVqc3Y2VWFFZ3VOZy1rbDBMUzhWcHY0WDNuRGt6aVBxQlRBM01fcjhlRHVqdjFKc3BERUxMVzFIdFVMWHJxV1diLWhTN0JPdjVuSlRhSkx2eWQ0VC1ZSjhmZlMwX0ozU0g5OXNpZFRIWkJ6TWZIbXNtTnZrNVZKTVAzU0piMDQ2SThHQjN4UWd5YXhr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxORjVqc3Y2VWFFZ3VOZy1rbDBMUzhWcHY0WDNuRGt6aVBxQlRBM01fcjhlRHVqdjFKc3BERUxMVzFIdFVMWHJxV1diLWhTN0JPdjVuSlRhSkx2eWQ0VC1ZSjhmZlMwX0ozU0g5OXNpZFRIWkJ6TWZIbXNtTnZrNVZKTVAzU0piMDQ2SThHQjN4UWd5YXhr?oc=5\" target=\"_blank\">Where Will Vertex Pharmaceuticals Be in 5 Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-11-27T08:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Should You Be Confident in Vertex Pharmaceuticals Incorporated’s (VRTX) Long-Term Outlook? - Insider Monkey",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Should You Be Confident in Vertex Pharmaceuticals Incorporated’s (VRTX) Long-Term Outlook?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>",
      "published": "2025-12-29T13:48:15+00:00",
      "source": "Insider Monkey"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5\" target=\"_blank\">Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-05-06T07:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-31",
      "close": 453.3599853515625
    },
    "history": [
      {
        "date": "2025-12-22",
        "close": 460.30999755859375
      },
      {
        "date": "2025-12-23",
        "close": 459.2099914550781
      },
      {
        "date": "2025-12-24",
        "close": 462.989990234375
      },
      {
        "date": "2025-12-26",
        "close": 462.8999938964844
      },
      {
        "date": "2025-12-29",
        "close": 459.7799987792969
      },
      {
        "date": "2025-12-30",
        "close": 453.739990234375
      },
      {
        "date": "2025-12-31",
        "close": 453.3599853515625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}